TOPICAL STEROID WITHDRAWAL (RED SKIN SYNDROME)

Course overview

TOPICAL CORTICOSTEROID WITHDRAWAL, ALSO KNOWN AS RED SKIN SYNDROME, IS AN INCREASINGLY RECOGNIZED DERMATOLOGICAL CONDITION OCCURRING AFTER PROLONGED MISUSE OF MEDIUM- TO HIGH-POTENCY TOPICAL CORTICOSTEROIDS. PRIMARILY AFFECTING AREAS SUCH AS THE FACE AND SCROTUM, THE SYNDROME MANIFESTS AS BURNING, ITCHING, AND ERYTHEMA UPON CESSATION OF STEROID USE. THE CONDITION ARISES FROM AN ADDICTION-LIKE DEPENDENCY ON THESE MEDICATIONS, EXACERBATED BY INAPPROPRIATE TOPICAL CORTICOSTEROID USE. TOPICAL CORTICOSTEROID WITHDRAWAL IS MORE COMMON IN WOMEN AND ADULT PATIENTS AND IS OFTEN LINKED TO THE TREATMENT OF CONDITIONS LIKE ATOPIC DERMATITIS WITHOUT MEDICAL SUPERVISION. THE PATHOPHYSIOLOGY INVOLVES FACTORS LIKE VASOCONSTRICTION, BARRIER DYSFUNCTION, AND A CYTOKINE CASCADE, LEADING TO VARIOUS SYMPTOMS, INCLUDING SKIN PAIN, BURNING, ERYTHEMA, DESQUAMATION, AND SYSTEMIC ISSUES LIKE FATIGUE AND MOOD CHANGES. DIAGNOSIS IS CHALLENGING DUE TO THE LACK OF CONSENSUS ON CRITERIA AND SIMILARITIES WITH OTHER SKIN CONDITIONS, INCLUDING CONTACT DERMATITIS. TREATMENT INCLUDES CESSATION OF STEROIDS, SUPPORTIVE CARE, AND MEDICATIONS LIKE GABAPENTIN OR IMMUNOSUPPRESSANTS FOR SYMPTOMATIC MANAGEMENT.THIS ACTIVITY WILL PROVIDE AN OVERVIEW OF TOPICAL CORTICOSTEROID WITHDRAWAL, THE CLINICAL PRESENTATION, DIAGNOSIS, MANAGEMENT, AND COMPLICATIONS. PARTICIPATING CLINICIANS ARE EQUIPPED WITH THE UNDERSTANDING OF TOPICAL CORTICOSTEROID WITHDRAWAL, EMPHASIZING THE IMPORTANCE OF RECOGNIZING THE CONDITION, THE UNDERLYING MECHANISMS, AND EMPLOYING EFFECTIVE MANAGEMENT STRATEGIES.